Georges-Pascal Haber, M.D.

Surgeon:

Yes

Treats:

Adults Only

Fellowship - Cleveland Clinic

Urology/Robotic Urology
Cleveland, OH USA
2010

Fellowship - Cleveland Clinic

Urology/Advanced Urological Laparoscopic
Cleveland, OH USA
2009

Research Fellowship - Cleveland Clinic

Urology/Advanced Urological Laparoscopic
Cleveland, OH USA
2008

Residency - Centre Hospitalier Regional Universitaire de Lille

Urology
Lille France
2004

Medical School - University Joseph Fourier

Grenoble France
2000

• American Urological Association Best Audio-Visual Award, 2006, 2007, 2008, 2009
• Endourological Society Essay Contest Award 2006, 2009
• Engineering & Urology Society Best Paper Awards, 2007, 2008
• World Congress of Endourology Best Research Paper, 2006, 2008
• Cleveland Clinic Medical Innovation Summit First Prize, 2007
• American Urological Association Best Abstract, 2006
• French Association of Urology Best Overall Research Paper Award, 2006
• European Association of Urology Best Paper Award, 2005

Dr. Haber has played a pioneering role in the development of scar-free kidney and prostate surgery performed through the belly button. He performed the first-ever scar-free removal of a healthy kidney for transplant in Europe. Dr. Haber also assisted in the first-ever scar-free NOTES Transvaginal Nephrectomy for kidney disease.

Dr. Haber pioneered the concept and initial development of stereotactic navigation for percutaneous cryoablation of kidney cancer. He has also helped refine the technique of robotic partial nephrectomy for treatment of kidney cancer.

Dr. Haber contributed to the development of the robotic laser technique for treating prostate cancer.

• American Urological Association
• European Association of Urology
• French Association of Urology
• Endourological Society

• Adrenal Surgery
• Adrenalectomy
• Bladder Surgery
• Cryotherapy
• Image-Guided Surgery
• Kidney Surgery
• Kidney with Pancreas Transplantation
• Laparoscopic Surgery
• Prostate Biopsy
• Radical Cystectomy
• Robotic Nephrectomy
• Robotic Prostate Surgery
• Robotic Prostatectomy
• Robotic Surgery
• Single-Port Radical Prostatectomy
• Single-port Surgery
• Urinary Reconstruction and Diversion

• Adrenal disorders
• Adrenal Tumors
• Adrenocortical Carcinoma
• Benign Prostatic Enlargement (BPH)
• Bladder Cancer
• Elevated PSA
• Hematuria
• Hydronephrosis
• Kidney Cancer
• Kidney Cysts, Simple
• Kidney donation
• Pheochromocytoma
• Polycystic Kidney Disease
• Prostate Cancer
• Retroperitoneal Fibrosis
• Ureteral Cancer
• Ureteral Strictures
• Ureteropelvic Junction (UPJ) Obstruction
• Von Hippel-Lindau Disease (VHL)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 3/15/2010 the review process regarding Dr. Haber’s disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

• English
• French